{"id":5504,"date":"2026-10-01T00:00:39","date_gmt":"2026-09-30T16:00:39","guid":{"rendered":"https:\/\/www.pgeneral.com\/?p=5504"},"modified":"2026-09-29T18:41:18","modified_gmt":"2026-09-29T10:41:18","slug":"gc-ms-for-nitrosamine-screening-what-pharmaceutical-labs-should-check-before-method-transfer","status":"publish","type":"post","link":"https:\/\/www.pgeneral.com\/tr\/news\/gc-ms-for-nitrosamine-screening-what-pharmaceutical-labs-should-check-before-method-transfer","title":{"rendered":"Nitrozamin Taramas\u0131 i\u00e7in GC-MS: \u0130la\u00e7 Laboratuvarlar\u0131 Y\u00f6ntem Aktar\u0131m\u0131ndan \u00d6nce Neleri Kontrol Etmelidir?"},"content":{"rendered":"<div style=\"text-align: center;\">\n<p style=\"text-align: left;\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-5499\" src=\"https:\/\/www.pgeneral.com\/wp-content\/uploads\/2026\/09\/GC-MS-for-Nitrosamine-Screening-What-Pharmaceutical-Labs-Should-Check-Before-Method-Transfer.webp\" alt=\"Nitrozamin Taramas\u0131 i\u00e7in GC-MS: \u0130la\u00e7 Laboratuvarlar\u0131 Y\u00f6ntem Aktar\u0131m\u0131ndan \u00d6nce Neleri Kontrol Etmelidir?\" width=\"750\" height=\"529\" srcset=\"https:\/\/www.pgeneral.com\/wp-content\/uploads\/2026\/09\/GC-MS-for-Nitrosamine-Screening-What-Pharmaceutical-Labs-Should-Check-Before-Method-Transfer.webp 750w, https:\/\/www.pgeneral.com\/wp-content\/uploads\/2026\/09\/GC-MS-for-Nitrosamine-Screening-What-Pharmaceutical-Labs-Should-Check-Before-Method-Transfer-300x212.webp 300w, https:\/\/www.pgeneral.com\/wp-content\/uploads\/2026\/09\/GC-MS-for-Nitrosamine-Screening-What-Pharmaceutical-Labs-Should-Check-Before-Method-Transfer-18x12.webp 18w, https:\/\/www.pgeneral.com\/wp-content\/uploads\/2026\/09\/GC-MS-for-Nitrosamine-Screening-What-Pharmaceutical-Labs-Should-Check-Before-Method-Transfer-600x423.webp 600w\" sizes=\"(max-width: 750px) 100vw, 750px\" \/><\/p>\n<p style=\"text-align: left;\">Bir nitrozamin y\u00f6ntemi, g\u00f6nderen laboratuvarda iyi \u00e7al\u0131\u015fabilir ancak transferden sonra yine de sorun ya\u015fayabilir. Yeni tesis farkl\u0131 bir giri\u015f astar\u0131, kolon ge\u00e7mi\u015fi, otomatik numuneleyici, gaz beslemesi, veri sistemi veya numune haz\u0131rlama rutini kullan\u0131yor olabilir. \u0130z seviyelerinde, bu k\u00fc\u00e7\u00fck farkl\u0131l\u0131klar art\u0131k k\u00fc\u00e7\u00fck de\u011fildir. Bo\u015f numune kontaminasyonu, geri kazan\u0131m kayb\u0131, kal\u0131nt\u0131 veya belirsiz tan\u0131mlama olarak ortaya \u00e7\u0131karlar.<\/p>\n<p style=\"text-align: left;\">GC-MS, baz\u0131 NDMA analiz i\u015f ak\u0131\u015flar\u0131 da dahil olmak \u00fczere, se\u00e7ilmi\u015f u\u00e7ucu veya GC'ye uygun bile\u015fikler i\u00e7in g\u00fc\u00e7l\u00fc bir y\u00f6ntem olabilir. Ancak her nitrozamin veya her ila\u00e7 matrisi i\u00e7in evrensel bir \u00e7\u00f6z\u00fcm de\u011fildir. Nitrozamin testi i\u00e7in, ilgili laboratuvar\u0131n analit kimyas\u0131, haz\u0131rlama, ay\u0131rma, dedekt\u00f6r yan\u0131t\u0131 ve raporlama e\u015fi\u011finin \u00f6nerilen y\u00f6nteme uygun oldu\u011funu do\u011frulamas\u0131 gerekir.<\/p>\n<h2 style=\"text-align: left;\"><strong><b>GC-MS y\u00f6nteminin hedef analitler i\u00e7in uygun oldu\u011funu do\u011frulay\u0131n.<\/b><\/strong><\/h2>\n<p style=\"text-align: left;\">\u0130lk transfer sorusu, sahan\u0131n bir GC-MS cihaz\u0131na sahip olup olmad\u0131\u011f\u0131 de\u011fil, y\u00f6ntemin hedef listesinin se\u00e7ilen haz\u0131rl\u0131k ve gaz kromatografisi ko\u015fullar\u0131ndan kay\u0131p, d\u00f6n\u00fc\u015f\u00fcm veya giri\u015fim olmaks\u0131z\u0131n ge\u00e7ip ge\u00e7emeyece\u011fidir. U\u00e7uculuk, termal davran\u0131\u015f, polarite ve matris y\u00fck\u00fc bu de\u011ferlendirmeyi etkiler.<\/p>\n<h3 style=\"text-align: left;\"><strong><b>Analit Listesini ve Numune Alma Rotas\u0131n\u0131 Tan\u0131mlay\u0131n<\/b><\/strong><\/h3>\n<p style=\"text-align: left;\">Hedef nitrozaminlerin, i\u00e7 standartlar\u0131n, ekstraksiyon \u00e7\u00f6z\u00fcc\u00fclerinin, numune k\u00fctlelerinin, seyreltme, filtrasyon veya temizleme ad\u0131mlar\u0131n\u0131n ve tam giri\u015f yollar\u0131n\u0131n her birini kaydedin. Do\u011frudan s\u0131v\u0131 enjeksiyonu, headspace ve t\u00fcrevlendirme tabanl\u0131 yakla\u015f\u0131mlar birbirinin yerine kullan\u0131labilen y\u00f6ntemler olu\u015fturmaz. Her biri kolona ula\u015fan maddeyi ve tespit \u00f6ncesinde olu\u015fabilecek veya kaybolabilecek maddeleri de\u011fi\u015ftirir.<\/p>\n<h3 style=\"text-align: left;\"><strong><b>Alternatif Teknikleri Kapsamda Tutun<\/b><\/strong><\/h3>\n<p style=\"text-align: left;\">Baz\u0131 analitler veya matrisler, LC-MS tabanl\u0131 prosed\u00fcrler veya ba\u015fka bir do\u011frulanm\u0131\u015f teknikle daha iyi i\u015flenebilir. Bu nedenle, bir GC-MS nitrozamin y\u00f6nteminin, kapsamad\u0131\u011f\u0131 bile\u015fikleri de i\u00e7erecek \u015fekilde tan\u0131mlanm\u0131\u015f bir kapsam\u0131 olmal\u0131d\u0131r. FDA'n\u0131n <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/control-nitrosamine-impurities-human-drugs\"><strong><u>nitrosamin k\u0131lavuzu<\/u><\/strong><\/a>\u00a0Bu durum, \u00fcreticilere riski de\u011ferlendirme ve uygun hassasiyette analitik prosed\u00fcrler kullanma sorumlulu\u011funu y\u00fckler. Ancak, her \u00fcr\u00fcn i\u00e7in tek bir platformun uygun oldu\u011fu anlam\u0131na gelmez.<\/p>\n<h2 style=\"text-align: left;\"><strong><b>Sadece dosyay\u0131 de\u011fil, \u00f6rnek giri\u015f ve ayr\u0131m\u0131n\u0131 da aktar\u0131n.<\/b><\/strong><\/h2>\n<p style=\"text-align: left;\">Bir y\u00f6ntem dosyas\u0131 s\u0131cakl\u0131klar\u0131 ve zamanlamay\u0131 yeniden \u00fcretebilir. Ancak bir giri\u015fin ko\u015fullar\u0131n\u0131, bir analistin al\u0131\u015fkanl\u0131klar\u0131n\u0131 veya bir \u015fi\u015fe raf\u0131n\u0131n kirlenme ge\u00e7mi\u015fini yeniden \u00fcretemez. Transfer plan\u0131, al\u0131c\u0131 tesisin i\u015f ak\u0131\u015f\u0131n\u0131 yeniden olu\u015fturabilmesi i\u00e7in sarf malzemelerini ve haz\u0131rl\u0131k ayr\u0131nt\u0131lar\u0131n\u0131 yeterli hassasiyetle tan\u0131mlamal\u0131d\u0131r.<\/p>\n<h3 style=\"text-align: left;\"><strong><b>Zorlu Bo\u015fluklar, Devaml\u0131l\u0131k ve Matris Y\u00fcklemesi<\/b><\/strong><\/h3>\n<p style=\"text-align: left;\">Y\u00fcksek standart veya temsili bir numuneden sonra reaktif bo\u015f numuneleri, haz\u0131rl\u0131k bo\u015f numuneleri, \u00e7\u00f6z\u00fcc\u00fc bo\u015f numuneleri ve bo\u015f enjeksiyonlar ger\u00e7ekle\u015ftirin. \u0130z miktardaki kontaminasyon su, \u00e7\u00f6z\u00fcc\u00fcler, plastik e\u015fyalar, septalar, astarlar, cam e\u015fyalar veya ortak haz\u0131rl\u0131k alanlar\u0131ndan kaynaklanabilir. Desen \u00f6nemlidir. Y\u00fcksek bir enjeksiyondan sonra y\u00fckselen bir bo\u015f numune, dizinin ba\u015flamas\u0131ndan \u00f6nce mevcut olan kontaminasyondan farkl\u0131 bir nedene i\u015faret eder.<\/p>\n<h3 style=\"text-align: left;\"><strong><b>Kromatografik Se\u00e7icili\u011fi Yeniden Olu\u015fturma<\/b><\/strong><\/h3>\n<p style=\"text-align: left;\">Al\u0131c\u0131 laboratuvar, kolon faz\u0131n\u0131 ve boyutlar\u0131n\u0131, ta\u015f\u0131y\u0131c\u0131 gaz kalitesini, giri\u015f modunu, astar\u0131, enjeksiyon hacmini, f\u0131r\u0131n program\u0131n\u0131, transfer hatt\u0131 durumunu ve tutunma davran\u0131\u015f\u0131n\u0131 do\u011frulamal\u0131d\u0131r. Bir matris bile\u015feninin izlenen iyonlar\u0131 payla\u015ft\u0131\u011f\u0131 durumlarda birlikte el\u00fcsyon \u00f6zellikle tehlikelidir. Tutunma uyumu, iyon oranlar\u0131, pik \u015fekli ve matris bo\u015fluklar\u0131, tek bir nitelendiricinin tan\u0131mlamay\u0131 \u00fcstlenmesine izin vermek yerine birlikte incelenmelidir.<\/p>\n<h2 style=\"text-align: left;\"><strong><b>Koruma Tan\u0131mlama ve Nicelle\u015ftirme<\/b><\/strong><\/h2>\n<p style=\"text-align: left;\">Farmas\u00f6tik safs\u0131zl\u0131k testlerinde hem g\u00fcvenilir bir kimlik hem de savunulabilir bir say\u0131 gereklidir. Aktar\u0131m protokol\u00fcnde, tutma s\u00fcresi, kantlay\u0131c\u0131 ve niteleyici iyonlar, iyon oran\u0131 toleranslar\u0131, entegrasyon, kalibrasyon modeli, a\u011f\u0131rl\u0131kland\u0131rma ve i\u00e7 standart yan\u0131t\u0131n\u0131n nas\u0131l de\u011ferlendirilece\u011fi belirtilmelidir. Bu ayr\u0131nt\u0131lar, analistin haf\u0131zas\u0131nda de\u011fil, kontroll\u00fc y\u00f6ntemde yer almal\u0131d\u0131r. GC-MS nitrozamin \u00e7al\u0131\u015fmalar\u0131, kimlik kurallar\u0131 yaln\u0131zca bir matris piki ortaya \u00e7\u0131kt\u0131ktan sonra ayarland\u0131\u011f\u0131nda savunulmas\u0131 zorla\u015f\u0131r.<\/p>\n<p style=\"text-align: left;\"><img decoding=\"async\" class=\"aligncenter size-full wp-image-5503\" src=\"https:\/\/www.pgeneral.com\/wp-content\/uploads\/2026\/09\/researchers-observed-experiments.webp\" alt=\"Ara\u015ft\u0131rmac\u0131lar deneyleri g\u00f6zlemledi.\" width=\"500\" height=\"333\" srcset=\"https:\/\/www.pgeneral.com\/wp-content\/uploads\/2026\/09\/researchers-observed-experiments.webp 500w, https:\/\/www.pgeneral.com\/wp-content\/uploads\/2026\/09\/researchers-observed-experiments-300x200.webp 300w, https:\/\/www.pgeneral.com\/wp-content\/uploads\/2026\/09\/researchers-observed-experiments-18x12.webp 18w\" sizes=\"(max-width: 500px) 100vw, 500px\" \/><\/p>\n<h3 style=\"text-align: left;\"><strong><b>Matrisi yans\u0131tan kalibrasyon kullan\u0131n.<\/b><\/strong><\/h3>\n<p style=\"text-align: left;\">\u00c7\u00f6z\u00fcc\u00fc standartlar\u0131, cihaz tepkisini ortaya \u00e7\u0131karabilir ancak ekstraksiyon kayb\u0131n\u0131 veya matris bask\u0131lanmas\u0131n\u0131 ve artmas\u0131n\u0131 temsil etmeyebilir. Uygun yerlerde \u00e7\u00f6z\u00fcc\u00fc ve matris e\u015fle\u015fmeli tepkileri kar\u015f\u0131la\u015ft\u0131r\u0131n, ard\u0131ndan y\u00f6nteme uygun seviyelerde katk\u0131 maddesi geri kazan\u0131m\u0131n\u0131 de\u011ferlendirin. Kalibrasyon noktalar\u0131n\u0131n say\u0131s\u0131 ve yerle\u015fimi, a\u011f\u0131rl\u0131kland\u0131rma ve izin verilen kal\u0131nt\u0131 deseni, ilgisiz bir \u00fcr\u00fcnden kopyalanmak yerine laboratuvar\u0131n prosed\u00fcr\u00fcyle gerek\u00e7elendirilmelidir.<\/p>\n<h3 style=\"text-align: left;\"><strong><b>Tekrarlar Yap\u0131n, S\u00fcreci A\u00e7\u0131klay\u0131n<\/b><\/strong><\/h3>\n<p style=\"text-align: left;\">Tekrarlanabilirlik, yaln\u0131zca tek bir \u015fi\u015feden tekrarlanan enjeksiyonlar\u0131 de\u011fil, ba\u011f\u0131ms\u0131z haz\u0131rl\u0131klar\u0131 da kapsamal\u0131d\u0131r. Enjeksiyon tekrarlar\u0131, cihaz\u0131 ve otomatik \u00f6rnekleyiciyi test eder. Haz\u0131rl\u0131k tekrarlar\u0131 ayr\u0131ca tart\u0131m, ekstraksiyon, seyreltme, transfer ve temizleme i\u015flemlerini de zorlar. Her ikisi de faydal\u0131d\u0131r, ancak farkl\u0131 sorulara cevap verirler. Bir GC-MS y\u00f6ntem do\u011frulama paketi, \u00f6zellikle NDMA analizinin u\u00e7ucu bir hedefi ekleyebilecek veya kaybedebilecek bir haz\u0131rl\u0131k ad\u0131m\u0131na ba\u011fl\u0131 oldu\u011fu durumlarda, bu ayr\u0131m\u0131 g\u00f6r\u00fcn\u00fcr k\u0131lmal\u0131d\u0131r.<\/p>\n<h2 style=\"text-align: left;\"><strong><b>Al\u0131c\u0131 Laboratuvarda Performans\u0131 Yeniden Sa\u011flay\u0131n<\/b><\/strong><\/h2>\n<p style=\"text-align: left;\">\u0130lk standart bir pik \u00fcretti\u011finde y\u00f6ntem aktar\u0131m\u0131 tamamlanm\u0131\u015f say\u0131lmaz. Al\u0131c\u0131 merkez, y\u00f6ntemin kendi analistleri, ekipman\u0131, ortam\u0131 ve \u00fcr\u00fcn matrisleri i\u00e7in performans g\u00f6sterdi\u011fini kan\u0131tlamal\u0131d\u0131r. Kapsam, y\u00f6ntemin durumuna ve laboratuvar\u0131n kalite sistemine ba\u011fl\u0131 olarak do\u011frulama, k\u0131smi do\u011frulama veya daha geni\u015f kapsaml\u0131 GC-MS y\u00f6ntem do\u011frulamas\u0131 olabilir.<\/p>\n<h3 style=\"text-align: left;\"><strong><b>LOD ve LOQ'yu Ger\u00e7ek Gereksinime G\u00f6re Belirleyin<\/b><\/strong><\/h3>\n<p style=\"text-align: left;\">Alg\u0131lama ve nicelle\u015ftirme yetene\u011fi, ilgili matriste ve ger\u00e7ek haz\u0131rlama fakt\u00f6r\u00fcyle g\u00f6sterilmelidir. Sinyal-g\u00fcr\u00fclt\u00fc oran\u0131 de\u011ferlendirmeyi destekleyebilir, ancak tek kan\u0131t olmamal\u0131d\u0131r. Do\u011fruluk, hassasiyet, tepki kararl\u0131l\u0131\u011f\u0131, bo\u015f numune davran\u0131\u015f\u0131 ve raporlama gereksinimleri de \u00f6nemlidir. Bir cihaz bro\u015f\u00fcr\u00fcnden evrensel bir LOD, LOQ veya d\u00fczenleyici limit atanmamal\u0131d\u0131r; laboratuvar ve tedarik\u00e7i, mevcut \u00fcr\u00fcn ve yetkili kurum i\u00e7in gerekli performans\u0131 do\u011frulamal\u0131d\u0131r.<\/p>\n<h3 style=\"text-align: left;\"><strong><b>Yay\u0131nlanmadan \u00d6nce Kabul Kriterlerini Yaz\u0131n<\/b><\/strong><\/h3>\n<p style=\"text-align: left;\">Transfer numuneleri test edilmeden \u00f6nce sistem uygunlu\u011fu, kalibrasyon kabul\u00fc, bo\u015f numune limitleri, geri kazan\u0131m, hassasiyet, tutma davran\u0131\u015f\u0131, iyon oranlar\u0131, kal\u0131nt\u0131 ve yeniden enjeksiyon kurallar\u0131 tan\u0131mlanmal\u0131d\u0131r. FDA'n\u0131n <a href=\"https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/information-about-nitrosamine-impurities-medications\"><strong><u>nitrozamin safs\u0131zl\u0131klar\u0131 hakk\u0131nda kamuya a\u00e7\u0131k bilgiler<\/u><\/strong><\/a>\u00a0Mevcut d\u00fczenleyici ba\u011flam\u0131 takip etmek i\u00e7in faydal\u0131d\u0131r; saha prosed\u00fcr\u00fc ise y\u00f6nteme \u00f6zg\u00fc kriterleri ve onaylanm\u0131\u015f raporlama yolunu i\u00e7ermelidir.<\/p>\n<p style=\"text-align: left;\">Aktar\u0131m partisi, g\u00fcnl\u00fck ve analistler aras\u0131 varyasyonu ortaya \u00e7\u0131karacak kadar ba\u011f\u0131ms\u0131z preparat i\u00e7ermeli; ayr\u0131ca bir matris bo\u015flu\u011fu, g\u00fc\u00e7lendirilmi\u015f numuneler, kalibrasyon standartlar\u0131 ve kas\u0131tl\u0131 olarak s\u0131raya yerle\u015ftirilmi\u015f bir ta\u015f\u0131ma testi de i\u00e7ermelidir. Bir kriter ba\u015far\u0131s\u0131z oldu\u011funda, t\u00fcm partiyi tekrarlamadan \u00f6nce ba\u015far\u0131s\u0131z olan katman\u0131 inceleyin. Bo\u015fluk problemi, d\u00fc\u015f\u00fck geri kazan\u0131m, tutunma kaymas\u0131 ve iyon oran\u0131 hatas\u0131, s\u00fcrecin farkl\u0131 b\u00f6l\u00fcmlerine i\u015faret eder. Bu ayr\u0131m zaman kazand\u0131r\u0131r ve farmas\u00f6tik safs\u0131zl\u0131k test raporuna, bir dizi yedek enjeksiyon yerine g\u00fcvenilir bir a\u00e7\u0131klama sa\u011flar.<\/p>\n<h2 style=\"text-align: left;\"><strong><b>Cihaz\u0131n Uygunlu\u011funu, Kontaminasyon Kontrol\u00fcn\u00fc ve Kay\u0131tlar\u0131 Kontrol Edin<\/b><\/strong><\/h2>\n<p style=\"text-align: left;\">\u015eu <a href=\"https:\/\/www.pgeneral.com\/tr\/product\/m7\/\"><strong><u>M7'nin<\/u><\/strong><\/a>\u00a0Bu, EI kayna\u011f\u0131na, \u00e7ift filamana, 10 ila 100 eV aras\u0131nda ayarlanabilir elektron enerjisine, 350 dereceye kadar kaynak \u0131s\u0131tmas\u0131na ve birim k\u00fctle \u00e7\u00f6z\u00fcn\u00fcrl\u00fc\u011f\u00fc i\u00e7in tasarlanm\u0131\u015f bir molibden d\u00f6rt kutupluya sahip tek d\u00f6rt kutuplu bir GC-MS'dir. \u00c7\u0131kar\u0131labilir \u00f6n d\u00f6rt kutuplu filtresi, ana d\u00f6rt kutupluya ula\u015fan kontaminasyonu azaltmay\u0131 ama\u00e7lamaktad\u0131r. Bu \u00f6zellikler rutin servis ve kaynak temizli\u011fi i\u00e7in \u00f6nemlidir, ancak laboratuvar\u0131n yine de aktar\u0131lan y\u00f6ntem ve matris ile bir g\u00f6sterime ihtiyac\u0131 vard\u0131r.<\/p>\n<h3 style=\"text-align: left;\"><strong><b>Fiyat teklifi vermeden \u00f6nce yap\u0131land\u0131rmay\u0131 inceleyin.<\/b><\/strong><\/h3>\n<p style=\"text-align: left;\">Sistem, y\u00fcksek vakum pompalama se\u00e7enekleri, y\u00fcksek voltaj d\u00f6n\u00fc\u015ft\u00fcrme diyotuna sahip bir elektron \u00e7o\u011falt\u0131c\u0131 ve i\u015fletim ve veri i\u015fleme i\u00e7in bir i\u015f istasyonu i\u00e7erir. \u00d6n g\u00f6zlem penceresi, operat\u00f6r\u00fcn filament durumunu ve kolon yerle\u015fimini g\u00f6rmesini sa\u011flar. Sat\u0131n alma s\u0131ras\u0131nda, GC giri\u015fi, otomatik numuneleyici veya headspace se\u00e7ene\u011fi, pompa konfig\u00fcrasyonu, kolon, yaz\u0131l\u0131m fonksiyonlar\u0131, veri d\u0131\u015fa aktar\u0131m\u0131, denetim ihtiya\u00e7lar\u0131, kurulum yeterlili\u011fi ve servis paketini onaylay\u0131n. Daha geni\u015f kapsaml\u0131 <a href=\"https:\/\/www.pgeneral.com\/tr\/product-category\/kromatografi\/\"><strong><u>kromatografi portf\u00f6y\u00fc<\/u><\/strong><\/a>\u00a0Bu yap\u0131land\u0131rma sorular\u0131n\u0131, her se\u00e7ene\u011fin temel M7'de yer ald\u0131\u011f\u0131n\u0131 ima etmeden form\u00fcle edebiliriz.<\/p>\n<h3 style=\"text-align: left;\"><strong><b>Transfer Paketini Denetime Haz\u0131r Tutun<\/b><\/strong><\/h3>\n<p style=\"text-align: left;\">Son paket, onaylanm\u0131\u015f y\u00f6ntemi, transfer protokol\u00fcn\u00fc, cihaz konfig\u00fcrasyonunu, kromatogramlar\u0131, entegrasyon kay\u0131tlar\u0131n\u0131, hesaplamalar\u0131, sapmalar\u0131, ara\u015ft\u0131rmalar\u0131, e\u011fitimi ve son raporu i\u00e7ermelidir. \u0130z \u00e7al\u0131\u015fmalar\u0131n\u0131 etkileyen bak\u0131m ve kontaminasyon kontrollerini de i\u00e7ermelidir: kaynak temizli\u011fi, astar ve septum de\u011fi\u015fimleri, kolon kesimi, s\u0131z\u0131nt\u0131 kontrolleri, filament ge\u00e7mi\u015fi, ayar durumu ve bo\u015f numune e\u011filimleri. Sa\u011flam bir nitrozamin testi transferi ayr\u0131ca GC-MS yolunun neden se\u00e7ildi\u011fini ve kapsam\u0131n\u0131n nerede sona erdi\u011fini de kaydetmelidir. <a href=\"https:\/\/www.pgeneral.com\/tr\/\"><strong><u>Pansiyon<\/u><\/strong><\/a>\u00a0Bu y\u00f6ntem, cihaz yap\u0131land\u0131rmas\u0131 ve bak\u0131m ayr\u0131nt\u0131lar\u0131n\u0131n do\u011frulanmas\u0131na yard\u0131mc\u0131 olabilir, ancak y\u00f6ntemin kabul\u00fc laboratuvar\u0131n kalite karar\u0131na ba\u011fl\u0131d\u0131r.<\/p>\n<h2 style=\"text-align: left;\"><strong><b>S\u0131k Sorulan Sorular<\/b><\/strong><\/h2>\n<p style=\"text-align: left;\"><strong>S1: Tek bir GC-MS y\u00f6ntemi t\u00fcm nitrozaminleri kapsayabilir mi?<\/strong><\/p>\n<p style=\"text-align: left;\">A1: Hay\u0131r. Uygunluk, analit kimyas\u0131na, u\u00e7uculu\u011funa, termal davran\u0131\u015f\u0131na, haz\u0131rlan\u0131\u015f\u0131na, matrisine, ayr\u0131m\u0131na ve gerekli hassasiyete ba\u011fl\u0131d\u0131r. Baz\u0131 hedefler i\u00e7in LC-MS veya di\u011fer do\u011frulanm\u0131\u015f y\u00f6ntemler gerekebilir.<\/p>\n<p style=\"text-align: left;\"><strong>S2: Transfer paketlerinde en s\u0131k rastlanan zay\u0131f nokta nedir?<\/strong><\/p>\n<p style=\"text-align: left;\">A2: Bir\u00e7ok paket, cihaz ayarlar\u0131n\u0131 tan\u0131mlar ancak sarf malzemelerini, bo\u015f sekanslar\u0131, entegrasyon kurallar\u0131n\u0131, kontaminasyon kontrollerini ve haz\u0131rl\u0131k ayr\u0131nt\u0131lar\u0131n\u0131 atlar. Bu eksiklikler, eser miktardaki farkl\u0131l\u0131klar\u0131n ara\u015ft\u0131r\u0131lmas\u0131n\u0131 zorla\u015ft\u0131r\u0131r.<\/p>\n<p style=\"text-align: left;\"><strong>S3: GC-MS tedarik\u00e7isiyle nelerin teyit edilmesi gerekiyor?<\/strong><\/p>\n<p style=\"text-align: left;\">A3: Giri\u015f, otomatik numuneleyici, dedekt\u00f6r, yaz\u0131l\u0131m, kalifikasyon, sarf malzemeleri, servis ve y\u00f6nteme \u00f6zg\u00fc performans\u0131n do\u011frulanmas\u0131.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>A nitrosamine method can run well at the sending laboratory and still struggle after transfer. The new site may use a different inlet liner, column history, autosampler, gas supply, data system, or sample preparation routine. At trace levels, those small differences are not small anymore. They show up as blank contamination, recovery loss, carryover, or [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5499,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[38,37],"tags":[],"class_list":["post-5504","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry-information","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.pgeneral.com\/tr\/wp-json\/wp\/v2\/posts\/5504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pgeneral.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pgeneral.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pgeneral.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pgeneral.com\/tr\/wp-json\/wp\/v2\/comments?post=5504"}],"version-history":[{"count":3,"href":"https:\/\/www.pgeneral.com\/tr\/wp-json\/wp\/v2\/posts\/5504\/revisions"}],"predecessor-version":[{"id":5513,"href":"https:\/\/www.pgeneral.com\/tr\/wp-json\/wp\/v2\/posts\/5504\/revisions\/5513"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pgeneral.com\/tr\/wp-json\/wp\/v2\/media\/5499"}],"wp:attachment":[{"href":"https:\/\/www.pgeneral.com\/tr\/wp-json\/wp\/v2\/media?parent=5504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pgeneral.com\/tr\/wp-json\/wp\/v2\/categories?post=5504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pgeneral.com\/tr\/wp-json\/wp\/v2\/tags?post=5504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}